Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: The population-based cross-sectional ERA-JUMP study

American Journal of Clinical Nutrition

Volumn 91, Issue 5, 2010, Pages 1195-1203

  Choo, Jina ^a,b   Ueshima, Hirotsugu ^c   Curb, J David ^d   Shin, Chol ^e   Evans, Rhobert W ^b   El Saed, Aiman ^b   Kadowaki, Takashi ^c   Okamura, Tomonori ^b,c,f   Nakata, Katsumi ^b   Otake, Teruo ^b,c,f   Miura, Katsuyuki ^c   Abbott, Robert D ^g   Sutton Tyrrell, Kim ^b   Edmundowicz, Daniel ^h   Kuller, Lewis H ^b   Sekikawa, Akira ^b  

^a Korea University   (South Korea)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF HAWAII   (United States)

^e Korea University College of Medicine   (South Korea)

^f NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^g UNIVERSITY OF VIRGINIA   (United States)

^h UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; TRANS FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASIAN AMERICAN; BLOOD SAMPLING; BODY MASS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; GAS LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; JAPANESE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SMOKING;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FATTY ACIDS, OMEGA-6; HUMANS; HYPERTENSION; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PATIENT SELECTION; REGRESSION ANALYSIS; SMOKING;

EID: 77951940099     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28500     Document Type: Article

References (48)

1. Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 2007;55:217-223
2. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-1499
3. Iso H, Sato S, Umemura U, et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002;33:2086-2093
4. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol 2005;161:672-679 (Pubitemid 40411095)
5. Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005;165:193-199
6. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146-1155
7. Gardner CD, Kraemer HC. Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995;15:1917-1927
8. Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009;119: 902-907
9. Willett WC. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med (Hagerstown) 2007;8(suppl 1):S42-5.
10. Miura K, Stamler J, Nakagawa H, et al. Relationship of dietary linoleic acid to blood pressure. The International Study of Macro-Micronutrients and Blood Pressure Study. Hypertension 2008;52:408-414
11. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009;119:931-939
12. Kuller L, Arnold A, Tracy R, et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol 2002;22: 1175-1180 (Pubitemid 34764870)
13. Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002;106:1930-1937 (Pubitemid 35176297)
14. Cromwell WC, Otvos JD, Keyes MJ, et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - implications for LDL management. J Clin Lipidol 2007;1:583-592
15. Mora S, Szklo M, Otvos JD, et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007;192:211-217
16. Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study. Am J Cardiol 2002;90:71i-6i. (Pubitemid 35284913)
17. Wilkinson P, Leach C, Ah-Sing EE, et al. Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 2005;181:115-124 (Pubitemid 40804701)
18. Thijssen MA, Mensink RP. Small differences in the effects of stearic acid, oleic acid, and linoleic acid on the serum lipoprotein profile of humans. Am J Clin Nutr 2005;82:510-516 (Pubitemid 43759233)
19. Motoyama KR, Curb JD, Kadowaki T, et al. Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men. Am J Clin Nutr 2009;90:49-55.
20. Sekikawa A, Curb JD, Ueshima H, et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008;52:417-424 (Pubitemid 352043837)
21. Sekikawa A, Ueshima H, Kadowaki T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-World War II birth cohort. Am J Epidemiol 2007;165:617-624 (Pubitemid 46348375)
22. Abbott RD, Ueshima H, Rodriguez BL, et al. Coronary artery calcification in Japanese men in Japan and Hawaii. Am J Epidemiol 2007;166: 1280-1287 (Pubitemid 350129415)
23. Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 2002;48:171-180 (Pubitemid 34272531)
24. Sekikawa A, Ueshima H, Sutton-Tyrrell K, et al. Intima-media thickness of the carotid artery and the distribution of lipoprotein subclasses in men aged 40 to 49 years between whites in the United States and the Japanese in Japan for the ERA JUMP study. Metabolism 2008;57:177-182
25. Freedman DS, Otvos JD, Jeyarajah EJ, et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 2004;50:1189-1200
26. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917
27. Yeh LLL, Bunker CH, Evans RW, Kuller LH. Serum fatty acid distributions in postmenopausal women. Nutr Res 1994;14:675-691 (Pubitemid 24139262)
28. Nelson GJ, Schmidt PC, Bartolini G, et al. The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids 1997; 32:427-433 (Pubitemid 27173071)
29. Kusumoto A, Ishikura Y, Kawashima H, Kiso Y, Takai S, Miyazaki M. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet. Br J Nutr 2007;98:626-635 (Pubitemid 47277259)
30. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007;193:1-10. (Pubitemid 46776717)
31. Barter PJ, Ballantyne CM, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006;259:247-258
32. Otvos JD, Collins D, Freedman DS, et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006;113: 1556-1563 (Pubitemid 43739414)
33. Mustad VA, Ellsworth JL, Cooper AD, Kris-Etherton PM, Etherton TD. Dietary linoleic acid increases and palmitic acid decreases hepatic LDL receptor protein and mRNA abundance in young pigs. J Lipid Res 1996; 37:2310-2323
34. Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 2002;90:89-94.
35. Valsta LM, Jauhiainen M, Aro A, Katan MB, Mutanen M. Effects of a monounsaturated rapeseed oil and a polyunsaturated sunflower oil diet on lipoprotein levels in humans. Arterioscler Thromb 1992;12:50-57
36. Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000; 7:325-331
37. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006;38:52-63.
38. Rosenson RS. Clinical role of LDL and HDL subclasses and apolipoprotein measurement. ACC Curr J Rev 2004;13:33-37
39. Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003;52: 453-462 (Pubitemid 36173203)
40. Summers LK, Fielding BA, Bradshaw HA, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002;45:369-377
41. Lee JS, Pinnamaneni SK, Eo SJ, et al. Saturated, but not n-6 poly-unsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 2006;100:1467-1474
42. Seyberth HW, Oelz O, Kennedy T, et al. Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther 1975;18:521-529
43. Oikawa D, Tsuyama S, Akimoto Y, Mizobe Y, Furuse M. Arachidonic acid prevents fatty liver induced by conjugated linoleic acid in mice. Br J Nutr 2009;101:1558-1563
44. Kinlaw WB, Quinn JL, Wells WA, Roser-Jones C, Moncur JT. Spot 14: a marker of aggressive breast cancer and a potential therapeutic target. Endocrinology 2006;147:4048-4055 (Pubitemid 44268359)
45. Mensink RP, Katan MB. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 1989; 321:436-441
46. Arab L. Biomarkers of fat and fatty acid intake. J Nutr 2003;133(suppl 3):925S-32S. (Pubitemid 36262800)
47. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M, Tsugane S. Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr 2001;55:643-650 (Pubitemid 32776487)
48. Dreon DM, Vranizan KM, Krauss RM, Austin MA, Wood PD. The effects of polyunsaturated fat vs monounsaturated fat on plasma lipoproteins. JAMA 1990;263:2462-2466 (Pubitemid 20169458)